Moreover , CYP2C19 genotypes that are known to influence the effect of clopidogrel did not influence the effect of ticagrelor .
Ticagrelor has improved pharmacokinetic and pharmacodynamic profiles compared to currently available drugs for treating ACS .
CYP2C19 genotypes that are known to influence the effect of clopidogrel did not influence the effect of ticagrelor .
Ticagrelor has improved pharmacokinetic and pharmacodynamic profiles compared to currently available drugs for treating ACS .